Pages that link to "Q40115548"

The following pages link to In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents (Q40115548):

Displaying 47 items.

• KASL clinical practice guidelines: management of chronic hepatitis B (Q26752475) (← links)
• The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs (Q26781795) (← links)
• Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus (Q28551711) (← links)
• Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study (Q33608997) (← links)
• Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir (Q33857643) (← links)
• Complex dynamics of hepatitis B virus resistance to adefovir (Q34208672) (← links)
• Effect and mechanism of beta-L-D4A on DNA polymerase alpha (Q34225266) (← links)
• Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C (Q34489239) (← links)
• Tenofovir disoproxil fumarate: in chronic hepatitis B. (Q34613098) (← links)
• Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates (Q34647599) (← links)
• Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis (Q34847029) (← links)
• Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients (Q34948124) (← links)
• New approaches in the management of chronic hepatitis B: role of tenofovir. (Q35026531) (← links)
• Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study (Q35487430) (← links)
• Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety (Q35535861) (← links)
• High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B. (Q35890599) (← links)
• Randomized Trial of Entecavir plus Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B Who Show Suboptimal Response to Lamivudine plus Adefovir (Q36018658) (← links)
• KASL Clinical Practice Guidelines: Management of chronic hepatitis B. (Q36153966) (← links)
• Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures (Q36492640) (← links)
• Antiviral efficacy of entecavir versus entecavir plus adefovir for hepatitis B virus rtA181V/T mutants alone (Q36606780) (← links)
• Review of tenofovir-emtricitabine. (Q36663686) (← links)
• Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection (Q36932959) (← links)
• Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients. (Q36969950) (← links)
• Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells (Q37212962) (← links)
• Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade (Q37229851) (← links)
• Antiviral resistance and hepatitis B therapy (Q37255008) (← links)
• Efficacy and safety of tenofovir-based rescue therapy for chronic hepatitis B patients with previous nucleo(s/t)ide treatment failure. (Q37564039) (← links)
• Management of Antiviral Resistance in Chronic Hepatitis B. (Q37696029) (← links)
• Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients (Q37738814) (← links)
• Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation (Q37760897) (← links)
• Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied? (Q37762114) (← links)
• Molecular diagnosis and treatment of drug-resistant hepatitis B virus (Q38219020) (← links)
• Management of antiviral drug resistance in chronic hepatitis B (Q38247981) (← links)
• Nonpolar nucleoside mimics as active substrates for human thymidine kinases (Q39986281) (← links)
• Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs (Q40555175) (← links)
• Tenofovir and its potential in the treatment of hepatitis B virus. (Q41435482) (← links)
• Clonal evolution of hepatitis B virus polymerase gene mutations during lamivudine-adefovir combination treatment (Q42131024) (← links)
• Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B? (Q43105141) (← links)
• Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B. (Q44418225) (← links)
• Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection. (Q45368315) (← links)
• Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B monoinfection. (Q46044243) (← links)
• Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016). (Q47585685) (← links)
• High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on (Q56982718) (← links)
• Discovery of the Novel Entecavir-Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis (Q58727285) (← links)
• Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients? (Q60952819) (← links)
• Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications (Q64085670) (← links)
• KASL clinical practice guidelines for management of chronic hepatitis B. (Q64897844) (← links)